Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

Posters by Session

Select Session

Thumbnail for Overall Survival Differs by Treatment Setting in Older Adults With Classical Hodgkin Lymphoma: A National Cancer Database Analysis

HL - 1340

Overall Survival Differs by Treatment Setting in Older Adults With Classical Hodgkin Lymphoma: A National Cancer Database Analysis

Nikki Verma

Poster Presenter: Nikki Verma

Thumbnail for PET-GUIDED NIVOLUMAB-BASED FIRST-LINE STRATEGY IN ADVANCED-STAGE CLASSICAL HODGKIN LYMPHOMA: INTERIM CLINICAL RESULTS

HL - 1412

PET-GUIDED NIVOLUMAB-BASED FIRST-LINE STRATEGY IN ADVANCED-STAGE CLASSICAL HODGKIN LYMPHOMA: INTERIM CLINICAL RESULTS

Hunan Julhakyan

Poster Presenter: Hunan Julhakyan

Thumbnail for Total Lesion Glycolysis on Interim PET/CT as a Predictor of Outcomes in Classic Hodgkin Lymphoma With Deauville Score 4-5: A Latin American Retrospective Cohort

Previous 1...78 79 80 81 82 83 84...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

HL - 1419

Total Lesion Glycolysis on Interim PET/CT as a Predictor of Outcomes in Classic Hodgkin Lymphoma With Deauville Score 4-5: A Latin American Retrospective Cohort

Andre Meireles

Poster Presenter: Andre Meireles

Thumbnail for Redefining "Safe" Anthracycline Limits: A Restricted Cubic Spline Meta-Analysis of Continuous Cumulative Dosing and Non-Linear Cardiotoxicity in Hodgkin Lymphoma Survivors

HL - 1461

Redefining "Safe" Anthracycline Limits: A Restricted Cubic Spline Meta-Analysis of Continuous Cumulative Dosing and Non-Linear Cardiotoxicity in Hodgkin Lymphoma Survivors

Haroon Alamy

Poster Presenter: Haroon Alamy

Thumbnail for Second Primary Malignancy Risk Among Survivors of Classical Hodgkin Lymphoma in the Pre- and Post-PD-1 Inhibitor Era

HL - 1463

Second Primary Malignancy Risk Among Survivors of Classical Hodgkin Lymphoma in the Pre- and Post-PD-1 Inhibitor Era

Olanipekun Lanny Ntukidem

Poster Presenter: Olanipekun Lanny Ntukidem

Thumbnail for Association of Immune Checkpoint Inhibitors (ICIs) With Sarcoidosis: Analysis of the FDA Adverse Event Reporting System (FAERS)

HL - 1484

Association of Immune Checkpoint Inhibitors (ICIs) With Sarcoidosis: Analysis of the FDA Adverse Event Reporting System (FAERS)

Arifa Bibi

Poster Presenter: Arifa Bibi

Thumbnail for Low-Dose Nivolumab Combined With AVD Chemotherapy for Advanced Hodgkin Lymphoma: Interim Results of a Phase 2 Trial

HL - 155

Low-Dose Nivolumab Combined With AVD Chemotherapy for Advanced Hodgkin Lymphoma: Interim Results of a Phase 2 Trial

Mobil Akhmedov

Poster Presenter: Mobil Akhmedov

Thumbnail for Real-World Uptake of Frontline Brentuximab Vedotin in Classical Hodgkin Lymphoma: A National Cancer Database Analysis

HL - 1598

Real-World Uptake of Frontline Brentuximab Vedotin in Classical Hodgkin Lymphoma: A National Cancer Database Analysis

Rita Ahmad

Poster Presenter: Rita Ahmad

Thumbnail for Attention Is All You Need for De-Escalation: A Time-Series Transformer Meta-Analysis of Dynamic PET Kinetics and Toxicity in Hodgkin Lymphoma

HL - 1613

Attention Is All You Need for De-Escalation: A Time-Series Transformer Meta-Analysis of Dynamic PET Kinetics and Toxicity in Hodgkin Lymphoma

Faiza Khalid

Poster Presenter: Faiza Khalid

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors